An observational study in Intracranial Atherosclerosis, sponsored by Sohag University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2024-04-18.
Sponsored by Sohag University · Observational
The purpose of this study is to assess short and long term outcomes of stenting for symptomatic intracranial arterial stenosis.
93 studies on the registry are indexed under Intracranial Arteriosclerosis; 41 are open to participants now.
This study's enrollment of 43 is below the median of 275 across 32 observational studies indexed under Intracranial Arteriosclerosis.
Browse Intracranial Arteriosclerosis studies →Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with symptomatic intracranial arterial stenosis caused by intracranial atherosclerosis
Exclusion Criteria:
Cerebrovascular events
Any stroke (including ischemic or hemorrhagic stroke) or TIA after stenting within the territory of the target vessel.
Time frame: 30 days after stenting
Death
Death after stenting within the territory of target vessel.
Time frame: 30 days after stenting
Cerebrovascular events
Ischemic or hemorrhagic stroke within the territory of the target vessel.
Time frame: 30 days to1 year after stenting
Death
Vascular death after stenting within the territory of target vessel
Time frame: 30 days to1 year after stenting
Complications
During the peri-operative period, complications such as vasospasms, acute thrombosis, vascular rupture, cerebral infarction, and cerebral haemorrhage will be recorded.
Time frame: Peri-operative period
Number of participants with restenosis
Magnetic resonance angiography (MRA) will be used to calculate the number and incidence of restenosis among all participants.
Time frame: 1 year after stenting
The degree of restenosis of the target vessel
The degree of restenosis will be assessed by performing magnetic resonance angiography (MRA) using the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) trial method for the measurements of arterial stenosis.
Time frame: 1 year after stenting
Change from baseline in The National Institutes of Health Stroke Scale (NIHSS) score
The National Institutes of Health Stroke Scale (NIHSS) score is a tool used to objectively quantify the impairment caused by a stroke and to evaluate stroke severity. It ranges from 0 to 42, with 42 being the highest and 0 being the lowest. The higher the NIHSS score, the worse the neurological function.
Time frame: Baseline and 30 days after stenting
Change from baseline in modified Rankin Scale (mRS) score
The modified Rankin Scale (mRS) score is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke.it ranges from 0 to 6 .The higher the mRS score, the worse the prognosis.
Time frame: Baseline and 30 days after stenting
Change from baseline in The National Institutes of Health Stroke Scale (NIHSS) score
The National Institutes of Health Stroke Scale (NIHSS) score is a tool used to objectively quantify the impairment caused by a stroke and to evaluate stroke severity. It ranges from 0 to 42, with 42 being the highest and 0 being the lowest. The higher the NIHSS score, the worse the neurological function.
Time frame: Baseline and 1 year after stenting
Change from baseline in modified Rankin Scale (mRS) score
The modified Rankin Scale (mRS) score is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke.it ranges from 0 to 6 .The higher the mRS score, the worse the prognosis.
Time frame: Baseline and 1 year after stenting
This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Intracranial Arteriosclerosis→
Sohag University